CJC1295

CJC1295/Ipamorelin is a combination of two peptides, a GHRH (growth hormone releasing hormone) and GHRP (growth hormone releasing peptide), all in one. Both of these peptides work together synergistically to amplify the pulse to promote the release of growth hormone.

The primary purpose of CJC-1295 is to boost protein synthesis levels and help fuel the growth of muscle tissues in the body. CJC 1295 was developed to treat diseases and medical conditions for patients who had muscle disorders, diseases, and burn victims.